Nanjing Hicin Pharmaceutical Co Ltd
SZSE:300584
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanjing Hicin Pharmaceutical Co Ltd
SZSE:300584
|
CN |
|
S
|
Spetz Inc
CNSX:SPTZ
|
CA |
|
V
|
Vikas Lifecare Ltd
NSE:VIKASLIFE
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Nanjing Hicin Pharmaceutical Co Ltd's stock price target?
Not Available
Nanjing Hicin Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Nanjing Hicin Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%
For the last 10 years the
compound annual growth rate for
Nanjing Hicin Pharmaceutical Co Ltd's revenue is
10%.
The projected
CAGR
for the next 5 years is
13%.
What is Nanjing Hicin Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 10 years the
compound annual growth rate for
Nanjing Hicin Pharmaceutical Co Ltd's net income is
2%.
The projected
CAGR
for the next 5 years is
21%.
